Cancer Ablation Devices Market

Cancer Ablation Devices Market contains market size and forecasts of Cancer Ablation Devices in global, including the following market information:

Global Cancer Ablation Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cancer Ablation Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Cancer Ablation Devices companies in 2021 (%)

The global Cancer Ablation Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cryoablation Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Ablation Devices include Alfresa Pharma Corp., AngioDynamics, Inc., BTG plc (Galil Medical Ltd./Perseon Medical), Biomedical S.r.l., Boston Scientific Corporation, CSA Medical, Inc., Chongqing Haifu Medical Technology Co., Ltd, ECO Medical and EDAP TMS S.A., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cancer Ablation Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Ablation Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cancer Ablation Devices Market Segment Percentages, by Type, 2021 (%)

Cryoablation

High-Intensity Focused Ultrasound (HIFU)

Laser Interstitial Thermal Therapy (LiTT)

Microwave Ablation (MWA)

Radiofrequency Ablation (RFA)

Irreversible Electroporation (Ire)

Non-Thermal Ablation

Global Cancer Ablation Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cancer Ablation Devices Market Segment Percentages, by Application, 2021 (%)

Brain Cancer

Brown

Colorectal Cancer

Kidney Cancer

Liver Cancer

Lung Cancer

Pancreatic Cancer

Prostate Cancer

Global Cancer Ablation Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cancer Ablation Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cancer Ablation Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Cancer Ablation Devices revenues share in global market, 2021 (%)

Key companies Cancer Ablation Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Cancer Ablation Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Alfresa Pharma Corp.

AngioDynamics, Inc.

BTG plc (Galil Medical Ltd./Perseon Medical)

Biomedical S.r.l.

Boston Scientific Corporation

CSA Medical, Inc.

Chongqing Haifu Medical Technology Co., Ltd

ECO Medical

EDAP TMS S.A.

HS Hospital Service S.p.A.

IceCure Medical, Inc.

Johnson & Johnson (Ethicon, Inc.)

Kang-Yu Medical Co., Ltd.

MedLink Technologies LLC

MedWaves, Inc.